(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMMUNA

ST13

US500000087677513

Class

5

Filing

87677513

Registration

6228361

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

12/23/2025

Trademark type

Word

Nice classes

5

Filing date

11/08/2017

Registration date

12/22/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/22/2020

Last transaction

12/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/12/2017

First use in commerce

09/12/2017

Drawing code

4

Owner type

99

Owner location

Gamle Fredrikstad, NO

Examiner

SIMCOX,KYLE DUNCAN

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

G. A. (pessoa física)

Representatives

Danielle I. Mattessich Merchant & Gould P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals and medical preparationsfor enhancement or stimulation of the immune system; dietetic food for medical use; dietary supplements for humans; pharmaceutical preparationspreparations for neoplastic diseases such as cancersliver diseasesdiabetesallergiesaidsskin diseases; dietetic preparations adapted for medical usedietary supplementspowder productspowdered nutritional supplement drink mix; food supplements and dietary supplements; nutraceuticals for use as a dietary supplement; nutraceuticals for use as a dietary supplement for immunostimulants; nutraceuticals for the treatment of cancersliver diseasesdiabetesallergiesaidsskin diseases; medical mushroom ingredients for use in the pharmaceutical industriesprocessed shiitake fungi for enhancement or stimulation of the immune system; processed shiitake mushrooms for medicinal or therapeutic purposes; mushroom-based pharmaceuticals for the treatment of liver diseasesdiabetesallergiesaidsskin diseases; immunostimulants; immunostimulants for the purpose of improving survivalgrowth and modulating the microbial population in the digestive tract; functional food with a health beneficial or disease preventative effectfood supplementsmainly consisting of processed shiitake mushrooms for medicinal or therapeutic purposes; beta glucan for pharmaceutical or medical purposesfor enhancement or stimulation of the immune system; polysaccharide from shiitake mushroom for pharmaceutical or medical purposesfor enhancement or stimulation of the immune system; dietetic sugar for medical use; beverages containing beta glucanmushroom extract and shiitake mushroom extract for use as a nutritional supplement

Publications

History of USPTO decisions and trademark events.

42 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/22/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/22/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/17/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/16/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/14/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/14/2020

IUAF

USE AMENDMENT FILED

11/03/2020

EISU

TEAS STATEMENT OF USE RECEIVED

11/03/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/13/2020

EX3G

SOU EXTENSION 3 GRANTED

10/09/2020

EXT3

SOU EXTENSION 3 FILED

10/09/2020

EEXT

SOU TEAS EXTENSION RECEIVED

10/09/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/08/2020

EX2G

SOU EXTENSION 2 GRANTED

04/06/2020

EXT2

SOU EXTENSION 2 FILED

04/06/2020

EEXT

SOU TEAS EXTENSION RECEIVED

04/06/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/11/2019

EX1G

SOU EXTENSION 1 GRANTED

10/09/2019

EXT1

SOU EXTENSION 1 FILED

10/09/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/09/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/09/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/12/2019

PUBO

PUBLISHED FOR OPPOSITION

02/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/23/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/06/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/13/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2018

ALIE

ASSIGNED TO LIE

12/07/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/03/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/03/2018

NREV

NOTICE OF REVIVAL - E-MAILED

12/03/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/03/2018

PETG

PETITION TO REVIVE-GRANTED

12/03/2018

PROA

TEAS PETITION TO REVIVE RECEIVED

12/03/2018

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

10/03/2018

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

10/03/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/05/2018

GNRT

NON-FINAL ACTION E-MAILED

03/05/2018

CNRT

NON-FINAL ACTION WRITTEN

03/05/2018

DOCK

ASSIGNED TO EXAMINER

02/20/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/19/2017

NWAP

NEW APPLICATION ENTERED

11/11/2017

Continuous trademark protection

Get notified about every new filing that threatens IMMUNA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.